Cases 1 - 10 of 18
Catalyst Pharmaceuticals, Inc. et al v. Lupin Ltd. et al
as 1:2023cv00229
Plaintiff:
Catalyst Pharmaceuticals, Inc. and SERB SA
Defendant:
Lupin Ltd., Lupin Inc. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Theravance Biopharma R&D IP, LLC et al v. Lupin Inc. et al
as 1:2023cv00187
Plaintiff:
Theravance Biopharma R&D IP, LLC, Theravance Biopharma Ireland Limited, Theravance Biopharma US, Inc. and others
Defendant:
Lupin Inc., Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2022cv01061
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2022cv00639
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc. and Lupin Inc.
Counter Claimant:
Lupin Atlantis Holdings S.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Galderma Laboratories L.P. et al v. Lupin Inc. et al
as 1:2021cv01710
Plaintiff:
Galderma Laboratories L.P. and TCD Royalty Sub LP
Defendant:
Lupin Inc. and Lupin Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01408
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271
Supernus Pharmaceuticals, Inc. v. Lupin Limited et al
as 1:2021cv01293
Plaintiff:
Supernus Pharmaceuticals, Inc.
Defendant:
Lupin Limited, Lupin Atlantis Holdings S.A., Nanomi B.V. and others
Cause Of Action: 28 U.S.C. § 1338
Novartis Pharmaceuticals Corporation v. Lupin Inc.
as 1:2021cv01105
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Lupin Inc.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01042
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al
as 1:2021cv00229
Defendant:
Lupin Pharmaceuticals, Inc., Lupin Limited, Lupin Atlantis Holdings, S.A. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
